Novel Anticancer Targets and Drug Discovery in Post Genomic Age

E-ISSN： 1875-5968|5|1|53-63

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.5, Iss.1, 2005-01, pp. : 53-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deubiquitinating enzymes as novel anticancer targets

By Nicholson Benjamin Marblestone Jeffrey G Butt Tauseef R Mattern Michael R

Future Oncology, Vol. 3, Iss. 2, 2007-04 ,pp. : 191-199

Future Medicine

Access to resources Recommend Favorite

Resistance to Rapamycin: A Novel Anticancer Drug

By Huang S. Houghton P.J.

Cancer and Metastasis Reviews, Vol. 20, Iss. 1-2, 2001-03 ,pp. : 71-80

Springer Publishing Company

Access to resources Recommend Favorite

Repair and Translesion DNA Polymerases as Anticancer Drug Targets

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 431-447

Bentham Science Publishers

Access to resources Recommend Favorite

Soil DNA libraries for anticancer drug discovery

By Pettit Robin

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 1, 2004-07 ,pp. : 1-6

Springer Publishing Company

Access to resources Recommend Favorite

The Role of XRCC4 in Carcinogenesis and Anticancer Drug Discovery

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 209-219

Bentham Science Publishers

Access to resources Recommend Favorite